R&D

Morphic Loses Another Big Pharma as J&J Bails on Research Deal
BioSpace
Mon, 01/23/23 - 11:13 am
JNJ
Janssen
Morphic Therapeutic
R&D
Sanofi and CytoReason target IBD in expanded collaboration
Pharma Live
Mon, 01/23/23 - 11:03 am
Sanofi
CytoReason
IBD
R&D
Merck KGaA shrinks U.S. research team as layoffs continue to batter industry
Fierce Biotech
Mon, 01/23/23 - 10:48 am
Merck KGaA
layoffs
R&D
Gilead fosters growth with plans for new research center in California hometown
Fierce Biotech
Wed, 01/18/23 - 11:04 pm
Gilead Sciences
R&D
California
Qiagen picks up DNA forensics company for $150M
Endpoints
Mon, 01/9/23 - 10:23 am
R&D
forensic genetics
Qiagen
M&A
Verogen
Pfizer pivots from early-stage rare disease R&D, shifting to external innovation and putting assets up for sale
Fierce Biotech
Fri, 01/6/23 - 10:09 am
Pfizer
R&D
externalization
gene therapy
Rare Diseases
Biogen splits R&D executive role, promoting interim head Singhal
BioPharma Dive
Thu, 01/5/23 - 04:47 pm
Biogen
R&D
Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal
Fierce Biotech
Tue, 01/3/23 - 10:26 pm
Merck KGaA
R&D
PDS Biotechnology
How a US Recession Could Affect Biopharma
BioSpace
Thu, 12/22/22 - 10:54 am
economy
biotech
recession
clinical trials
R&D
pandemic
Catalent to build a new $40M analytical services facility in North Carolina's Research Triangle
Endpoints
Wed, 12/14/22 - 07:25 pm
Catalent
North Carolina
RTP
analytical services
R&D
AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure
Fierce Biotech
Wed, 12/14/22 - 10:44 am
Exicure
AbbVie
Ipsen
R&D
Teva-partnered MedinCell bags $42M loan for long-acting injectable R&D
Fierce Pharma
Wed, 11/30/22 - 10:35 am
MedinCell
Teva Pharmaceutical
injectables
R&D
Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs
BioSpace
Tue, 11/29/22 - 08:25 pm
Merck
BigHat Biosciences
R&D
artificial intelligence
Envisagenics Announces Research Collaboration with Bristol Myers Squibb
BioSpace
Tue, 11/29/22 - 10:40 am
Envisagenics
artificial intelligence
Bristol Myers Squibb
R&D
Black Friday for Spectrum as FDA lung cancer rejection prompts 75% cut to R&D workforce
Fierce Biotech
Mon, 11/28/22 - 10:40 am
Spectrum Pharmaceuticals
layoffs
R&D
FDA
Pozenveo
Novo Nordisk invests $74M to boost API manufacturing for clinical trials
Fierce Biotech
Tue, 11/22/22 - 10:52 am
Novo Nordisk
clinical trials
APIs
API manufacturing
R&D
Merck KGaA outlines plan to rev up drug R&D
BioPharma Dive
Mon, 11/21/22 - 06:36 pm
Merck KGaA
drug development
R&D
Nabriva halts R&D, lays off 40% of staff in commercial-focused pivot for survival
Fierce Biotech
Fri, 11/11/22 - 10:46 am
Nabriva Therapeutics
R&D
layoffs
Sivextro
Harbour BioMed, Moderna partner on immunotherapies development
Pharmaceutical Business Review
Fri, 11/11/22 - 10:34 am
Harbour BioMed
Nana Biosciences
Moderna Therapeutics
immunotherapies
R&D
IQVIA and Clalit Health to launch prime site in Israel
Clinical Trials Arena
Fri, 11/11/22 - 10:30 am
IQVIA
Clalit Health
Israel
R&D
clinical trials

Pages